{"id":310075,"date":"2026-10-15T11:27:59","date_gmt":"2026-10-15T05:57:59","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=310075"},"modified":"2026-10-15T11:27:59","modified_gmt":"2026-10-15T05:57:59","slug":"pharma-formulation-specialty-glycol-and-basmati-rice-stocks-roadmap-spotlight-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pharma-formulation-specialty-glycol-and-basmati-rice-stocks-roadmap-spotlight-list\/","title":{"rendered":"3 Pharma Formulation, Specialty Glycol and Basmati Rice Stocks With a Strong Future Roadmap: FDC, India Glycols and LT Foods"},"content":{"rendered":"

FDC Rs 348.55, P\/E 18.05. India Glycols Rs 349.85, P\/E 7.58. LT Foods Rs 418.05, P\/E 21.98. Closing prices of 14 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Pharma formulation, specialty glycol and basmati rice stocks with the clearest long-term roadmaps today include FDC in oral rehydration products such as Electral along with eye, ear and anti-infective formulations, India Glycols in glycols, spirits and ethanol, and specialty chemicals made from renewable feedstock and LT Foods in basmati and other rice products sold under well-known consumer brands and to export markets. FY26 revenue growth was 3.9% at FDC, 11.5% at India Glycols and 25.7% at LT Foods. P\/E stands at 18.05 for FDC (industry 37.59), 7.58 for India Glycols (industry 54.53) and 21.98 for LT Foods (industry 34.85). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.<\/p>\n<\/p><\/div>\n

Pharma formulation, specialty glycol and basmati rice stocks give investors exposure to health products, chemicals and food staples sold at home and abroad. Volumes, pricing and input costs decide how much of that demand turns into profit.<\/p>\n

Readers comparing pharma formulation, specialty glycol and basmati rice stocks should weigh growth, margins, cash flow and valuation together instead of leaning on any single number.<\/p>\n

This list covers three pharma formulation, specialty glycol and basmati rice stocks: FDC for oral rehydration products such as Electral along with eye, ear and anti-infective formulations, India Glycols for glycols, spirits and ethanol, and specialty chemicals made from renewable feedstock and LT Foods for basmati and other rice products sold under well-known consumer brands and to export markets. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n